Hing C. Wong - Jul 22, 2021 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Executive Officer, Director
Signature
/s/ Hing C. Wong
Stock symbol
HCWB
Transactions as of
Jul 22, 2021
Transactions value $
$5,020,000
Form type
4
Date filed
7/23/2021, 07:04 PM
Previous filing
Jul 19, 2021
Next filing
Aug 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Conversion of derivative security $0 +6.32M +147.39% $0.00 10.6M Jul 22, 2021 Direct F1
transaction HCWB Common Stock Conversion of derivative security $0 +2.95M +27.86% $0.00 13.6M Jul 22, 2021 Direct F2
transaction HCWB Common Stock Conversion of derivative security $0 +1.07M +7.9% $0.00 14.6M Jul 22, 2021 Direct F3
transaction HCWB Common Stock Purchase $5.02M +628K +4.29% $8.00 15.3M Jul 22, 2021 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCWB Series A Redeemable Preferred Stock Conversion of derivative security $0 -6.32M -100% $0.00* 0 Jul 22, 2021 Common Stock 6.32M Direct F1, F5
transaction HCWB Series B Redeemable Preferred Stock Conversion of derivative security $0 -2.95M -100% $0.00* 0 Jul 22, 2021 Common Stock 2.95M Direct F2, F6
transaction HCWB Series C Redeemable Preferred Stock Conversion of derivative security $0 -1.07M -100% $0.00* 0 Jul 22, 2021 Common Stock 1.07M Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares received upon the conversion of shares of Series A Redeemable Convertible Preferred Stock. Includes 902,977 shares purchased jointly by Hing C. Wong and Bee Yau Huang.
F2 Represents shares received upon the conversion of shares of Series B Redeemable Convertible Preferred Stock. Includes 1,525,714 shares purchased jointly by Hing C. Wong and Bee Yau Huang.
F3 Represents shares received upon the conversion of shares of Series C Redeemable Convertible Preferred Stock. All shares were purchased jointly by Hing C. Wong and Bee Yau Huang.
F4 Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share.
F5 Each share of the Series A Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
F6 Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
F7 Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.